Cytek® Biosciences Names Chris Williams Chief Operating Officer

October 31, 2022

https://www.globenewswire.com/news-release/2022/10/31/2545015/0/en/Cytek-Biosciences-Names-Chris-Williams-Chief-Operating-Officer.html

Experienced Biotech, Pharmaceutical Industry Leader to Guide Operations Growth and Scalability

FREMONT, Calif., Oct. 31, 2022 (GLOBE NEWSWIRE) — Cytek Biosciences, Inc. (Nasdaq:CTKB) today announced that Chris Williams has been appointed chief operating officer for the company. In this role, Williams will lead and execute the company’s global operations strategy to scale up its capability to support its mission as a full solution provider to its customers. Williams’ appointment is effective immediately, reporting directly to Dr. Wenbin Jiang, chairman and CEO of Cytek Biosciences.

Read more at globenewswire.com

Related news for (CTKB)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.